Correction: Orphazyme Announces Publication of 2021 Financial Results and Annual Report
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Christophe Bourdon News
Page 2 - Christophe Bourdon News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Christophe Bourdon. Real-time updates on events, politics, business and more.
Orphazyme Announces Publication of 2021 Financial Results and Annual Report
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Correction: Orphazyme Announces Publication of 2021
Orphazyme A/SCompany announcementNo. 30/2022                                                                        Annual reportwww.orphazyme.com Company...
Source: globenewswire.com
Anders Vadsholt takes over as CEO of Orphazyme
28.02.2022 - Company announcementNo. 08/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 28, 2022 – Orphazyme A/S (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a late-stage biopharmaceutical company, today announces that ...
Georges Gemayel Bo Jesper Hansen Christophe Bourdon Anders Vadsholt European Medicines Agency Drug Administration
Source: wallstreet-online.de
Anders Vadsholt takes over as CEO of Orphazyme
Anders Vadsholt takes over as CEO of Orphazyme - read this article along with other careers information, tips and advice on BioSpace
Georges Gemayel Bo Jesper Hansen Christophe Bourdon Anders Vadsholt Company Annual Report On Form Exchange Commission
Source: biospace.com
Chutes & Ladders—Pfizer poaches Roche's early R&D leader Pao to replace development chief
Pfizer picks from Roche's executive team, snagging pharma early R&D leader William Pao as the Big Pharma's next chief development officer. Leo Pharma poaches from ... a Danish meme stock for its new CEO, who will lead a reorganization of the dermatology biopharma. And Sio Gene Therapies CEO Cheruvu is out the door as Parkinson's program also hits the exit.
Source: fiercebiotech.com
Orphazyme provides regulatory update following Type A
Orphazyme A/SCompany announcement        No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential...
United States Christophe Bourdon Anders Vadsholt Drug Administration Exchange Commission Company Annual Report On Form
Source: globenewswire.com
Rodrigo Beenkens ouvre la nouvelle saison des "Enfants de choeur" sur Vivacité
Enfin ! Enfin les "enfants de choeur" ont repris le chemin des salles pour lenregistrement du rendez-vous culte sur...
Source: rtbf.be
Orphazyme announces restructuring to focus resources on
– June 28, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company, today announced a restructuring intended to enable the company to advance its corporate strategy and the development of arimoclomol for Niemann-Pick disease type C (NPC). The resulting cost savings include an approximate two thirds reduction in our global workforce. Orphazyme remains committed to pursuing regulatory approval in Europe and assessing a path forward for arimoclomol in the U.S. following r...
Source: globenewswire.com
Orphazyme announces restructuring to focus resources on supporting a path forward for ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Orphazyme announces restructuring to focus resources on supporting a path forward for ... ORPHAZYME A/SJune 28, 2021 GMT Orphazyme A/S - Copenhagen – June 28, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company, today announced a restructuring intended to enable the company to advance its corporate strategy and the development of arimoclomol for Niemann-Pick disease type...
Source: apnews.com